13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
The University of Texas M.D. Anderson Cancer Center
Development of synthetic lethality anticancer therapeutics.
The University of Texas M.D. Anderson Cancer Center
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).
The University of Texas M.D. Anderson Cancer Center
Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.
The University of Texas M.D. Anderson Cancer Center
Role of organic cation transporters in the renal secretion of nucleosides.
The University of Texas M.D. Anderson Cancer Center
6-Methoxy-N-alkyl isatin acylhydrazone derivatives as a novel series of potent selective cannabinoid receptor 2 inverse agonists: design, synthesis, and binding mode prediction.
The University of Texas M.D. Anderson Cancer Center
Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
The University of Texas M.D. Anderson Cancer Center
Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.
The University of Texas M.D. Anderson Cancer Center
Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.
The University of Texas M.D. Anderson Cancer Center
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.
The University of Texas M.D. Anderson Cancer Center
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure.
The University of Texas M.D. Anderson Cancer Center
Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A.
The University of Texas M.D. Anderson Cancer Center